These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Do epigenetic drug treatments hold the key to killing cancer progenitor cells? Byler S; Sarkar S Epigenomics; 2014 Apr; 6(2):161-5. PubMed ID: 24811783 [No Abstract] [Full Text] [Related]
3. Next-generation sequencing technologies for DNA methylation analyses in cancer genomics. Boerno ST; Grimm C; Lehrach H; Schweiger MR Epigenomics; 2010 Apr; 2(2):199-207. PubMed ID: 22121870 [TBL] [Abstract][Full Text] [Related]
4. Review-Epigenetic therapy for cancer. Saleem M; Abbas K; Manan M; Ijaz H; Ahmed B; Ali M; Hanif M; Farooqi AA; Qadir MI Pak J Pharm Sci; 2015 May; 28(3):1023-32. PubMed ID: 26004710 [TBL] [Abstract][Full Text] [Related]
6. Cancer epigenetics. Weber W Prog Mol Biol Transl Sci; 2010; 95():299-349. PubMed ID: 21075335 [TBL] [Abstract][Full Text] [Related]
7. Deciphering the cancer imprintome. Monk D Brief Funct Genomics; 2010 Jul; 9(4):329-39. PubMed ID: 20551091 [TBL] [Abstract][Full Text] [Related]
8. A look at the origins of cancer epigenetics. Cancer Discov; 2013 Jul; 3(7):713. PubMed ID: 23847337 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic analysis in the search for tumor suppressor genes. Han ZG Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966 [No Abstract] [Full Text] [Related]
10. Interplay between microRNAs and the epigenetic machinery: an intricate network. Iorio MV; Piovan C; Croce CM Biochim Biophys Acta; 2010; 1799(10-12):694-701. PubMed ID: 20493980 [TBL] [Abstract][Full Text] [Related]
11. Influence of genetic inheritance on global epigenetic states and cancer risk prediction with DNA methylation signature: challenges in technology and data analysis. Lee MP; Dunn BK Nutr Rev; 2008 Aug; 66 Suppl 1(Suppl 1):S69-72. PubMed ID: 18673495 [No Abstract] [Full Text] [Related]
12. [Colorectal carcinoma and DNA methylation]. Liu M; Shen S Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1266-70. PubMed ID: 20045925 [TBL] [Abstract][Full Text] [Related]
13. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment. Koturbash I; Beland FA; Pogribny IP Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867 [TBL] [Abstract][Full Text] [Related]
14. Analysis of promoter CpG island hypermethylation in cancer: location, location, location! van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408 [TBL] [Abstract][Full Text] [Related]
16. DNA hypermethylation as an epigenetic mark for oral cancer diagnosis. Radhakrishnan R; Kabekkodu S; Satyamoorthy K J Oral Pathol Med; 2011 Oct; 40(9):665-76. PubMed ID: 21649736 [TBL] [Abstract][Full Text] [Related]
17. The Methylated DNA Immunoprecipitation [MeDIP] to Investigate the Epigenetic Remodeling in Cell Fate Determination and Cancer Development. Masciarelli S; Bellissimo T; Iosue I; Fazi F Methods Mol Biol; 2016; 1379():69-76. PubMed ID: 26608290 [TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms involved in epigenetic alterations in cancer]. Toyota M; Suzuki H; Nishizaka T; Sato A; Yamashita T Gan To Kagaku Ryoho; 2010 Sep; 37(9):1650-3. PubMed ID: 20841926 [TBL] [Abstract][Full Text] [Related]